Clinical Trial Update: Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous Thromboembolism

View source ↗

Summary

This clinical trial update assesses the effectiveness and safety of low molecular weight heparin for venous thromboembolism in cancer patients with non-high ris…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Dalteparin (dalteparin)
• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Trio Grup Clinical Research | Conditions: Venous Thromboembolism | Status: UNKNOWN